Sign in
Taking people in United StatesNo phase

Electrical stimulation therapy for arm recovery after spinal cord or nerve injury

Tests MyndMove stimulation therapy for arm function in adults with spinal cord or nerve injuries.

Key facts

Who runs it
University of Miami
Where
Miami, United StatesSee the site
Trial code
Registry title
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
Status
Recruiting
People taking part
60 people, planned
Started
1 Nov 2024
Expected to end
31 Jan 2029
Type of study
Interventional, 4 groups
Treatments tested
  • MyndMove Short Term Therapy
  • Conventional Short Term Therapy
  • MyndMove Long Term Therapy
Record updated
23 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a spinal cord injury in the neck or upper back, or with a nerve injury in the arm. It tests electrical stimulation therapy (MyndMove) to help arm function.

Age
18 Years to 70 Years
Sex
All
Disease stage
Traumatic spinal cord injury at or above the T1 level, AIS grade A, B, C or D. People can be less than 6 months or more than 6 months after injury. Or a peripheral nerve injury, with or without spinal cord injury, before or after arm nerve transfer surgery. The surgery must be within 6 months, or 6 months or more ago. The doctor must find the person medically stable.
Earlier treatment
People with a nerve injury must be before or after arm nerve transfer surgery.
Biomarker or test result
A visible muscle contraction with electrical stimulation in at least one arm muscle. Movement signal in at least 1 arm muscle, shown by EMG (muscle activity test) or MEP (nerve signal test).

Main reasons for not taking part

  • Brain injury, stroke, multiple sclerosis or other conditions that affect movement
  • Severe muscle stiffness, dementia, depression or other major health problems
  • Skin damage, blood clots, unhealed arm fracture or pressure sore where stimulation is applied
  • Implanted nerve stimulator, heart pacemaker or lines in the heart
  • Pregnant, breastfeeding or planning pregnancy; alcohol or drug use disorder

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Neurological Injury:
  • Traumatic spinal cord injury (SCI): neurological level at or above T1 spinal cord level; AIS A, B, C or D impairment grade; Group 1 (Acute SCI): Deemed medically stable by medical practitioner, less than 6 months post-injury; Group 2 (Chronic SCI): More than 6 months post-injury; or
  • Peripheral nerve injury (PNI), with or without SCI, who are pre- or post- upper extremity (UE) nerve transfer surgery; Group 3 (Acute Pre- or Post-UE nerve transfer surgery): Deemed medically stable and safe/appropriate to participate in MyndMove UE FES therapy intervention by referring neurosurgeon within 6 months pre- or post-UE nerve transfer surgery; Group 4 (Chronic Post-UE nerve transfer surgery): Deemed medically stable and safe/appropriate to participate in MyndMove UE FES therapy intervention by referring neurosurgeon 6 months or more post-UE nerve transfer surgery; Has detectable residual connection in upper-limb muscles in at least one of the neurologically affected sides confirmed by a visible contraction when functional electrical stimulation (FES) is applied in at least one upper extremity muscle at baseline; Has detectable motor function in at least 1 upper extremity muscle on 1 neurologically affected side confirmed by voluntary electromyography (EMG) or detectable motor evoked potential (MEP) at the baseline assessment. 5. (Aim 2 only) Able to commit to intervention and assessment sessions over a maximum duration of 4 months

Who cannot take part

  • Individuals who require therapy or other care that could interfere with participation in the study
  • Individuals on investigational drugs or any other intervention known to have a potential impact on neuromotor function
  • Traumatic brain injury, stroke, multiple sclerosis, or other disorders that could affect neuromotor function
  • Major executive dysfunction, dementia, depression, neurocognitive impairments, or other major medical co-morbidities
  • Has contraindications for transcutaneous stimulation using FES such as breakdown of skin in the area that will come into contact with electrodes, thrombosis, or skin disease
  • Cardiac pacemaker or intracardiac lines
  • Individuals with substance disorders, including alcoholism and drug abuse
  • Severe spasticity that could prevent the study protocol as determined by the investigator
  • Poorly managed autonomic dysreflexia that could be triggered by FES
  • Unhealed upper extremity fracture, contracture, or pressure sore
  • Implanted neurostimulator (e.g., deep brain stimulation (DBS), epidural/subdural, vagal nerve stimulation (VNS))
  • Individuals who are pregnant, breastfeeding, or the desire to become pregnant during the study
  • In the opinion of the investigators, the study is not safe or appropriate for the participant

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial is currently available in United States.

  • University of Miami - Miami Project to Cure ParalysisMiami, United StatesContact: Matija Milosevic, PhDTaking people

About the trial

What the trial wants to find out

The purpose of this research is to examine the effects that functional electrical stimulation (FES) therapy has on the way the arms, brain and spinal cord work. The study team wants to understand what recovery looks like in persons with a spinal cord injury (SCI) or peripheral nerve injury (PNI) using the MyndMove (MyndTec Inc., Ontario, Canada) therapy system. This type of therapy uses stimulation to help people with SCI and other neurological conditions to perform common tasks, work out, or strengthen muscles.

The 4 groups in the trial

  • Acute SCI GroupTreatment being tested

    Individuals with traumatic spinal cord injury (SCI) with a neurological level at or above T1 spinal cord level; Abbreviated Injury Scale (AIS) A, B, C or D impairment grade; less than 6 months post injury. Participants in this group will be in the study for up to 12 weeks

    Treatment: MyndMove Short Term Therapy, Conventional Short Term Therapy, and MyndMove Long Term Therapy

  • Chronic SCI GroupTreatment being tested

    Individuals with traumatic spinal cord injury (SCI) with a neurological level at or above T1 spinal cord level; Abbreviated Injury Scale (AIS) A, B, C or D impairment grade; more than 6 months post injury. Participants in this group will be in the study for up to 12 weeks

    Treatment: MyndMove Short Term Therapy, Conventional Short Term Therapy, and MyndMove Long Term Therapy

  • Acute PNI GroupTreatment being tested

    Individuals with PNI that are within 6 months pre- or post-UE nerve transfer surgery. Participants in this group will be in the study for up to 12 weeks

    Treatment: MyndMove Short Term Therapy, Conventional Short Term Therapy, and MyndMove Long Term Therapy

  • Chronic PNI GroupTreatment being tested

    Individuals with PNI that are 6 months or more post-UE nerve transfer surgery. Participants in this group will be in the study for up to 12 weeks

    Treatment: MyndMove Short Term Therapy, Conventional Short Term Therapy, and MyndMove Long Term Therapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
Plain-language title
Electrical stimulation therapy for arm recovery after spinal cord or nerve injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06672458, who can take part
Record updated
23 April 2026